tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sana Biotechnology’s Strategic Focus on T1D Therapies Justifies Buy Rating
PremiumRatingsSana Biotechnology’s Strategic Focus on T1D Therapies Justifies Buy Rating
4M ago
Sana Biotechnology Reports Reduced Losses and Strong Liquidity
Premium
Company Announcements
Sana Biotechnology Reports Reduced Losses and Strong Liquidity
4M ago
Sana Biotechnology’s Strategic Shift and Financial Positioning Justify Buy Rating
Premium
Ratings
Sana Biotechnology’s Strategic Shift and Financial Positioning Justify Buy Rating
4M ago
Sana Biotechnology’s SC291 Study: A Promising Step in Autoimmune Disease Treatment
PremiumCompany AnnouncementsSana Biotechnology’s SC291 Study: A Promising Step in Autoimmune Disease Treatment
4M ago
Sana Biotechnology strength attributed to EMJ Capital long call
Premium
The Fly
Sana Biotechnology strength attributed to EMJ Capital long call
4M ago
Wedbush bullish on Sana Biotechnology, initiates with an Outperform
Premium
The Fly
Wedbush bullish on Sana Biotechnology, initiates with an Outperform
5M ago
Sana Biotechnology’s Strategic Advances and Positive FDA Feedback Bolster Buy Rating
PremiumRatingsSana Biotechnology’s Strategic Advances and Positive FDA Feedback Bolster Buy Rating
6M ago
Sana Biotechnology’s Promising Advances in Diabetes Treatment and Strong Financial Position Support Buy Rating
Premium
Ratings
Sana Biotechnology’s Promising Advances in Diabetes Treatment and Strong Financial Position Support Buy Rating
6M ago
Sana Biotechnology reports Q2 EPS (16c), consensus (21c)
Premium
The Fly
Sana Biotechnology reports Q2 EPS (16c), consensus (21c)
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100